ReOxy is a new medical device for breathing therapy, that treats a patient with individually dosed levels of reduced-oxygen (hypoxic) gas mixtures throughout the procedure.

Our advantages

New modality

New modality, that allows to reduce the intensity if hypoxic load without compromising the treatment efficacy – the IHHT mode

New algorithm

Algorithm for calculation of individual therapeutic dose

New device

New device to facilitate the interval hypoxic therapy method involving the biological feed-back with automatic calculation of individual treatment hypoxia dose

New technology

Way to dose hypoxic load based on response of human body to the inhale of gaseous mixture with reduced oxygen

ABOUT US

Ai Mediq S.A. is a young Health BioMed tech company headquartered in Luxembourg.

Company is focusing on development of therapeutic solutions based on individual cell protection mechanisms management following the concept of personalized medicine. Company developed and sells innovative hypoxic medical devices for treatment and rehabilitation of cardiovascular, neurological diseases and metabolic disorders.

Read more

OUR Partners

Manufacturing partner

ReOxy breathing therapy device is a device that was developed based on latest developments in medical devices and electronics.

ReOxy is manufactured by Bitmos GmbH and is CE marked and produced in full compliance to 93/42/EEC (Medical Devices Directive – MDD), facilitating high quality and safety of operation.

Clinical partners

To help us carry out our mission to provide our customers with innovative solutions that are vital to patient care, we continue to work with a variety of partners to develop and introduce leading edge technologies and products.

THE NEWS

New clinical trial in CHF patients

Ai Mediq is pleased to announce approval of new clinical trial named "Evaluation of clinical efficacy of interval hypoxic-hyperoxic trainings in treatment of patients with reduced ejection fraction of left ventricle (2-3 NYHA)

Read More

ESC Congress 2019 combined with WCC2019 in Paris

Ai Mediq is pleased to announce participation in the annual meeting of European Society of Cardiology (ESC Congress) 2019 which will take place this time in Paris, France. For the first time ...

Read More

Ai Mediq at Arab Health 2019: First national pavilion of Luxembourg

From January 28 till February 1, 2019, the Grand Duchy of Luxembourg (cooperation between the Ministry of the Economy, the Luxembourg Chamber and Commerce and the Luxembourg Trade and Investment Office in Abu Dhabi) had a national pavilion at Arab Health for the very first time. It was our pleasure meeting our customers and guest during Arab Health 2019 on First national pavilion of Luxembourg.…

Read More

Arab Health 2019

Ai Mediq announces it’s participation in largest professional event in MENA region – Arab Health 2018. The event will...

Read More
All news